Endocrinology News

BOSTON — Breast cancer survivors are more likely to have weight gain of 10% or more during follow-up compared with healthy controls, with the strongest predictors younger age at diagnosis and lower weight at baseline, data show.

BOSTON — In the first year after stopping anabolic steroid misuse, men had worse sexual function than those who continued using or never used the agents as well as more depression and anxiety, according to a presenter at ENDO 2024.

BOSTON — Younger adults are at greater cardiovascular disease risk if they have obesity for 10 years, but a single excess weight measurement does not predict risk for heart-related events over time, according to data presented at ENDO 2024.

BOSTON — Crinecerfont lowered androstenedione levels and allowed for lower glucocorticoid doses for children with classic congenital adrenal hyperplasia, according to findings from the CAHtalyst Pediatric phase 3 trial.

BOSTON — Continuous glucose monitoring has transformed the field of diabetes over the past 25 years. The technology can be used by both providers and people with diabetes to improve disease management, according to a speaker at ENDO 2024.

BOSTON — Adults with acromegaly previously controlled with standard of care experienced similar disease control with once-monthly injectable octreotide at 24 and 52 weeks, with no serious adverse events, data presented at ENDO 2024 show.

BOSTON — In a proof-of-concept study, women with obesity who took semaglutide reported enhanced taste perception, and researchers observed altered gene expression in their tongues and their brain reward response related to sweet tastes.

BOSTON — Girls and boys who experienced stress early in life were more likely than those with lower stress scores to use alcohol, nicotine and cannabis by age 13 years, according to a presenter at ENDO 2024.

BOSTON — Adults with congenital adrenal hyperplasia receiving an oral nonsteroidal treatment saw a marked reduction in daily glucocorticoid dose at 24 weeks with maintenance of androgen control compared with placebo, researchers reported.

BOSTON — Accumulating sedentary time during childhood was associated with increased risk for liver disease in young adulthood, but boosting light physical activity may lessen the risk, according to data presented at ENDO 2024.